Labcorp to Acquire Chiltern for Approximately $1.2 Billion in Cash, Advancing Its Leadership in Drug Development

Strengthens LabCorp’s position as a global life sciences company with leading diagnostics and drug development businesses Creates a market-leading contract research organization (CRO), with significant global scale and more than 20,000 employees Enhances customer solutions, including customized models for emerging biopharma clients, expanded functional service provider (FSP) solutions and leading oncology expertise Highly complementary customer […]